Cargando…
Retargeting of Viruses to Generate Oncolytic Agents
Oncolytic virus therapy is based on the ability of viruses to effectively infect and kill tumor cells without destroying the normal tissues. While some viruses seem to have a natural preference for tumor cells, most viruses require the modification of their tropism to specifically enter and replicat...
Autores principales: | Verheije, M. H., Rottier, P. J. M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3265223/ https://www.ncbi.nlm.nih.gov/pubmed/22312365 http://dx.doi.org/10.1155/2012/798526 |
Ejemplares similares
-
Retargeting Strategies for Oncolytic Herpes Simplex Viruses
por: Campadelli-Fiume, Gabriella, et al.
Publicado: (2016) -
HSV as A Platform for the Generation of Retargeted, Armed, and Reporter-Expressing Oncolytic Viruses
por: Menotti, Laura, et al.
Publicado: (2018) -
Generation of a Retargeted Oncolytic Herpes Virus Encoding Adenosine Deaminase for Tumor Adenosine Clearance
por: Gentile, Chiara, et al.
Publicado: (2021) -
Polymer stealthing and mucin-1 retargeting for enhanced pharmacokinetics of an oncolytic vaccinia virus
por: Hill, Claudia, et al.
Publicado: (2021) -
Molecular retargeting of antibodies converts immune defense against oncolytic viruses into cancer immunotherapy
por: Niemann, Julia, et al.
Publicado: (2019)